comparemela.com

Page 7 - Kronan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Swedish Match AB (publ) (OTCMKTS:SWMAF) Short Interest Down 40 3% in May

Swedish Match AB (publ) (OTCMKTS:SWMAF – Get Rating) saw a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 1,670,200 shares, a decrease of 40.3% from the April 30th total of 2,795,500 shares. Based on an average daily trading volume, of 12,500 shares, the days-to-cover […]

Swedish Match AB (publ) (SWMAY) – Research Analysts Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Swedish Match AB (publ) (OTCMKTS: SWMAY) in the last few weeks: 5/24/2022 – Swedish Match AB (publ) was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $11.00 price target on the stock. […]

Swedish Match AB (publ) (OTCMKTS:SWMAY) Sees Large Decline in Short Interest

Swedish Match AB (publ) (OTCMKTS:SWMAY – Get Rating) saw a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 10,800 shares, a decrease of 88.3% from the April 30th total of 92,000 shares. Based on an average daily trading volume, of 832,200 shares, the days-to-cover […]

Swedish Match AB (publ) (OTCMKTS:SWMAY) Upgraded by Zacks Investment Research to Buy

Swedish Match AB (publ) (OTCMKTS:SWMAY – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. The firm currently has a $11.00 price target on the stock. Zacks Investment Research‘s price objective suggests a potential upside […]

Stock Analysts Upgrades for May 24th (CLBS, OMAB, PKOH, SNSE, SPPI, SRZN, SUI, SURVF, SWIR, SWMAY)

Stock Analysts’ upgrades for Tuesday, May 24th: Caladrius Biosciences (NASDAQ:CLBS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $0.50 target price on the stock. According to Zacks, “Caladrius Biosciences, Inc. is an immunotherapy company which specializes in cell process optimization, development and […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.